Shire pays $4.9bn for NPS Pharmaceuticals
Shire PLC is paying $4.9bn or $46 per share (a 19% premium) to acquire public NPS Pharmaceuticals Inc. (gastrointestinal and orphan drugs).
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com